Journal List > J Nutr Health > v.49(4) > 1081443

J Nutr Health. 2016 Aug;49(4):213-222. Korean.
Published online August 31, 2016.  https://doi.org/10.4163/jnh.2016.49.4.213
© 2016 The Korean Nutrition Society
Coffee and metabolic syndrome: A systematic review and meta-analysis
Yujin Lee, Jakyung Son, Jiyoung Jang and Kyong Park
Department of Food and Nutrition, Yeungnam University, Gyeongbuk 38541, Korea.

To whom correspondence should be addressed. tel: +82-53-810-2879, Email: kypark@ynu.ac.kr
Received June 01, 2016; Revised June 14, 2016; Accepted August 09, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Abstract

Purpose

Coffee is the most frequently consumed food item in South Korea after rice and cabbage. Coffee contains various substances, including caffeine, cafestol, kahweol, chlorogenic acid, and many other known and unknown ingredients with some health benefits. Especially, cumulative evidence has shown that regular coffee use is associated with lower risk of type 2 diabetes, although limited and inconsistent data are available regarding metabolic syndrome.

Methods

This study reviewed all available scientific and epidemiologic evidence on coffee consumption, metabolic syndrome, and the association between them. Most epidemiologic research regarding this association was of a cross-sectional design, and a few case-control and cohort studies were available. We conducted meta-analysis with 11 observational studies investigated in Europe, America, and Asia. Summary odds ratios (OR) were calculated using a random-effects model.

Results

The overall OR of metabolic syndrome was 0.90 (95% Confidence Interval (CI), 0.81-0.99) for the highest category of coffee intake compared with the lowest intake category. These associations were stronger in populations of US and Europe (OR 0.84, 95% CI 0.76-0.94), whereas no association was observed in the Asian population (OR 1.00, 95% CI 0.81-1.23).

Conclusion

The review results indicate that frequent coffee consumption may be beneficial to metabolic syndrome, but the association between coffee consumption and metabolic syndrome may differ by nations or continents.

Keywords: coffee; metabolic syndrome; meta-analysis

Figures


Fig. 1
Flow diagram of study selection for meta-analysis
Click for larger image


Fig. 2
Forest plot of summary odds ratio of metabolic syndrome for the highest versus lowest categories of coffee consumption
Click for larger image


Fig. 3
Influence analysis of coffee consumption and metabolic syndrome among all selected studies
Click for larger image


Fig. 4
Funnel plot testing for publication bias
Click for larger image

Tables


Table 1
Criteria of metabolic syndrome by various organizations7, 8, 19, 32
Click for larger image


Table 2
Summary of the studies on the relationship between coffee consumption and metabolic syndrome
Click for larger image


Table 3
Pooled odds ratios/relative risks and 95% CI for coffee consumption and metabolic syndrome by subgroups
Click for larger image

Notes

This research was supported by Basic Science Research Programme through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A3049866).

References
1. Grigg D. The worlds of tea and coffee: patterns of consumption. GeoJournal 2002;57(4):283–294.
2. International Coffee Organization. Monthly coffee market report: August 2012 [Internet]. London: International Coffee Organization; 2012 [cited 2016 May 26].
3. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Cheongwon: Korea Centers for Disease Control and Prevention; 2011. Korea Health Statistic.
4. USDA'S Global Agriculture Information Network. Coffee market brief update: Korea - Republic of (GAIN report number: KS1109). Washington, D.C.: U.S. Department of Agriculture Foreign Agricultural Service; [2011 Feb 16]. [cited 2016 May 26].
5. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 2014;37(2):569–586.
6. Shang F, Li X, Jiang X. Coffee consumption and risk of the metabolic syndrome: a meta-analysis. Diabetes Metab 2016;42(2):80–87.
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association National Heart, Lung, and Blood InstituteDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112(17):2735–2752.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486–2497.
9. Ranheim T, Halvorsen B. Coffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005;49(3):274–284.
10. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001;153(4):353–362.
11. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294(1):97–104.
12. Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 2012;66(8):872–877.
13. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the atherosclerosis risk in communities study. Circulation 2008;117(6):754–761.
14. Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome. The Tromsø Study 1979-2001. Diabetes Res Clin Pract 2007;78(2):217–224.
15. Nordestgaard AT, Thomsen M, Nordestgaard BG. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol 2015;44(2):551–565.
16. Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A. Factors associated with metabolic syndrome in a mediterranean population: role of caffeinated beverages. J Epidemiol 2014;24(4):327–333.
17. Grosso G, Stepaniak U, Micek A, Topor-Mądry R, Pikhart H, Szafraniec K, Pająk A. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 2015;54(7):1129–1137.
18. Takami H, Nakamoto M, Uemura H, Katsuura S, Yamaguchi M, Hiyoshi M, Sawachika F, Juta T, Arisawa K. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol 2013;23(1):12–20.
19. Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol 2012;22(2):160–166.
20. Chang CS, Chang YF, Liu PY, Chen CY, Tsai YS, Wu CH. Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS One 2012;7(6):e38874.
21. Yen AM, Chiu YH, Chen LS, Wu HM, Huang CC, Boucher BJ, Chen TH. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 2006;83(5):1153–1160.
22. Ki NK, Lee HK, Cho JH, Kim SC, Kim NS. Factors affecting metabolic syndrome by lifestyle. J Phys Ther Sci 2016;28(1):38–45.
23. Kim HJ, Cho S, Jacobs DR Jr, Park K. Instant coffee consumption may be associated with higher risk of metabolic syndrome in Korean adults. Diabetes Res Clin Pract 2014;106(1):145–153.
24. Marventano S, Salomone F, Godos J, Pluchinotta F, DelRio D, Mistretta A, Grosso G. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr. 2016
Forthcoming 2016.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008–2012.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557–560.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177–188.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088–1101.
29. Egger M, DaveySmith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315(7109):629–634.
30. Cooper H, Hedges LV, Valentine JC. In: The handbook of research synthesis and meta-analysis. 2nd edition. New York (NY): Russell Sage Foundation; 2009.
31. Korean Endocrine Society Korean Society for the Study of Obesity. Management of obesity, 2010; recommendation. Endocrinol Metab 2010;25(4):301–304.
32. International Diabetes Federation. IDF worldwide definition of the metabolic syndrome [Internet]. Brussels: International Diabetes Federation; [cited 2016 May 26].
33. Matsuzawa Y. Metabolic syndrome--definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005;12(6):301.
34. Wan CJ, Lin LY, Yu TH, Sheu WH. Metabolic syndrome associated with habitual indulgence and dietary behavior in middle-aged health-care professionals. J Diabetes Investig 2010;1(6):259–265.
35. Driessen MT, Koppes LL, Veldhuis L, Samoocha D, Twisk JW. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 2009;63(4):536–542.
36. Song F, Oh J, Lee K, Cho MS. The effect of coffee consumption on food group intake, nutrition intake, and metabolic syndrome of Korean adults-2010; KNHANES(V-1). NFS J 2016;4:9–14.
37. Dos Santos PR, Ferrari GS, Ferrari CK. Diet, sleep and metabolic syndrome among a legal Amazon population, Brazil. Clin Nutr Res 2015;4(1):41–45.
38. Echeverri D, Montes FR, Cabrera M, Galán A, Prieto A. Caffeine's vascular hanisms of action. Int J Vasc Med 2010;2010:834060.
39. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010;75(3):R77–R87.
40. Gray J. Caffeine, coffee and health. Nutr Food Sci 1998;98(6):314–319.
41. Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000;39(2):127–153.
42. Westerterp-Plantenga M, Diepvens K, Joosen AM, Bérubé-Parent S, Tremblay A. Metabolic effects of spices, teas, and caffeine. Physiol Behav 2006;89(1):85–91.
43. Acheson KJ, Gremaud G, Meirim I, Montigon F, Krebs Y, Fay LB, Gay LJ, Schneiter P, Schindler C, Tappy L. Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Am J Clin Nutr 2004;79(1):40–46.
44. Andriantsitohaina R, Auger C, Chataigneau T, Étienne-Selloum N, Li H, Martínez MC, Schini-Kerth VB, Laher I. Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nutr 2012;108(9):1532–1549.
45. Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 2006;83(3):674–680.
46. Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F, Grosso G. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 2014;65(8):925–936.
47. Urgert R, Kosmeijer-Schuil TG, Katan MB. Intake levels, sites of action and excretion routes of the cholesterol-elevating diterpenes from coffee beans in humans. Biochem Soc Trans 1996;24(3):800–806.
48. Bak AA, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med 1989;321(21):1432–1437.
49. Buscemi S, Verga S, Batsis JA, Tranchina MR, Belmonte S, Mattina A, Re A, Rizzo R, Cerasola G. Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr 2009;63(10):1200–1205.
50. Pimentel GD, Zemdegs JC, Theodoro JA, Mota JF. Does longterm coffee intake reduce type 2 diabetes mellitus risk? Diabetol Metab Syndr 2009;1(1):6.
51. Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, Schubert G, Below P, Herling AW. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 1997;339(2):315–322.
52. Clifford MN. Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 2000;80(7):1033–1043.
53. Andrade-Cetto A, Wiedenfeld H. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 2001;78(2-3):145–149.
54. Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, Wasserman DH. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 2003;133(11):3529–3532.
55. Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, Saito I. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 2007;20(5):508–513.
56. Karthikesan K, Pari L, Menon VP. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem Biol Interact 2010;188(3):643–650.
57. Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 2016;111:272–282.
58. La SA, Lee JY, Kim do H, Song EL, Park JH, Ju SY. Low magnesium levels in adults with metabolic syndrome: a meta-analysis. Biol Trace Elem Res 2016;170(1):33–42.
59. Viani R. Physiologically active substances in coffee. In: Clarke RJ, Macrae R, editors. Coffee: Volume 3 Physiology. . London: Elsevier Applied Science; 1988. pp. 1-31.
60. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Fernando Costa. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol 2005;4(4):198–203.
61. Israel KD, Michaelis OE 4th, Reiser S, Keeney M. Serum uric acid, inorganic phosphorus, and glutamic-oxalacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose. Ann Nutr Metab 1983;27(5):425–435.
62. Raben A, Vasilaras TH, Møller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002;76(4):721–729.
63. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005;54(7):1907–1913.
64. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292(8):927–934.
65. Gil BI, Rho JH. Hazardous effect of dietary trans fats on human health and regulations. Korean J Food Cookery Sci 2007;23(6):1015–1024.
66. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001;20(1):5–19.
67. Han SN, Leka LS, Lichtenstein AH, Ausman LM, Schaefer EJ, Meydani SN. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 2002;43(3):445–452.
68. Renouf M, Marmet C, Guy P, Fraering AL, Longet K, Moulin J, Enslen M, Barron D, Cavin C, Dionisi F, Rezzi S, Kochhar S, Steiling H, Williamson G. Nondairy creamer, but not milk, delays the appearance of coffee phenolic acid equivalents in human plasma. J Nutr 2010;140(2):259–263.